Publication | Closed Access
Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers
37
Citations
19
References
2017
Year
Gastrointestinal OncologyMedicineBiliary CancerPharmacologyPathologyAnti-cancer AgentCancer TreatmentOxaliplatin ImprovesOncologyCancer ResearchAntiangiogenic Therapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1